BeOne Medicines Ltd. (ONC) Stock Forecast
Data as of Sep 18, 2026Healthcare · Current price $349.82 (-1.03%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
ONC vs Sector & Market
| Metric | ONC | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.26 | 2.42 |
| Analyst Count | 6 | 8 | 18 |
| Target Upside | +16.0% | +16187.2% | +19.5% |
| P/E Ratio | 170.44 | 3.74 | 38.51 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $1.60B | $1.64B | $1.66B | 4 |
| 2026-12-31 | $1.68B | $1.72B | $1.74B | 5 |
| 2027-03-31 | $1.56B | $1.59B | $1.61B | 3 |
| 2027-06-30 | $1.66B | $1.70B | $1.72B | 3 |
| 2027-09-30 | $1.70B | $1.73B | $1.75B | 3 |
| 2027-12-31 | $1.86B | $1.90B | $1.93B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $1.66 | $1.71 | $1.74 | 1 |
| 2026-12-31 | $1.95 | $2.01 | $2.04 | 1 |
| 2027-03-31 | $1.76 | $1.81 | $1.84 | 1 |
| 2027-06-30 | $2.15 | $2.21 | $2.25 | 1 |
| 2027-09-30 | $2.44 | $2.50 | $2.55 | 1 |
| 2027-12-31 | $4.01 | $4.12 | $4.20 | 1 |
Frequently Asked Questions
What is the analyst consensus for ONC?
The consensus among 6 analysts covering BeOne Medicines Ltd. (ONC) is Buy with an average price target of $400.67.
What is the highest price target for ONC?
The highest analyst price target for ONC is $451.00.
What is the lowest price target for ONC?
The lowest analyst price target for ONC is $367.00.
How many analysts cover ONC?
6 analysts have issued ratings for BeOne Medicines Ltd. in the past 12 months.
Is ONC a buy or sell right now?
Based on 6 analyst ratings, ONC has a consensus rating of Buy (2.00/5) with a +16.0% upside to the consensus target of $400.67.
What are the earnings estimates for ONC?
Analysts estimate ONC will report EPS of $1.71 for the period ending 2026-09-30, with revenue estimated at $1.64B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.